SCHEMBL1005739

SCHEMBL1005739

CC(C)/C=C/C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2254540 1.00
SCHEMBL1005740 1.00
SCHEMBL31449842 0.75
SCHEMBL11298691 0.75
SCHEMBL2991560 0.75
SCHEMBL12193974 0.75
SCHEMBL9022856 0.75
SCHEMBL2375313 0.75
SCHEMBL1435402 0.75
SCHEMBL27692964 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110207835-A1 Alpha, Beta, Unsaturated Nitriles as Fragrances GIVAUDAN SA (CH) 2011-08-25 US claimed
EP-2079436-B1 ALPHA, BETA, UNSATURATED NITRILES AS FRAGRANCES GIVAUDAN SA (CH) 2010-11-10 EP claimed
EP-2079436-A1 ALPHA, BETA, UNSATURATED NITRILES AS FRAGRANCES Givaudan SA (CH) 2009-07-22 EP claimed
WO-2008037105-A1 ALPHA, BETA, UNSATURATED NITRILES AS FRAGRANCES GIVAUDAN SA (CH) 2008-04-03 WO claimed
US-4320071-A CATALYTIC DISPROPORTIONATION PHILLIPS PETROLEUM COMPANY (US) 1982-03-16 US claimed
US-20250197402-A1 Tyrosine Kinase Inhibitors PRINCIPIA BIOPHARMA INC. (US) 2025-06-19 US disclosed
US-20240025918-A1 KRAS G12D Inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-01-25 US disclosed
US-20230151012-A1 TYROSINE KINASE INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2023-05-18 US disclosed
US-20230137110-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-05-04 US disclosed
US-20220220106-A1 QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF ACADEMY OF MILITARY MEDICAL SCIENCES (CN) 2022-07-14 US disclosed
US-11365196-B2 FGFR inhibitor and application thereof BETTA PHARMACEUTICALS CO., LTD. (CN) 2022-06-21 US disclosed
EP-2758051-B1 CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME (US) 2018-04-11 EP disclosed
WO-2008037105-A1 ALPHA, BETA, UNSATURATED NITRILES AS FRAGRANCES GIVAUDAN SA (CH) 2008-04-03 WO disclosed
EP-0663394-B1 Process for preparing 5-aminodihydropyrrole, intermediate thereof and process for preparing said intermediate SUMITOMO CHEMICAL CO (JP) 2002-11-13 EP disclosed
US-5498725-A Process for preparing 5-aminodihydropyrrole intermediate thereof and process for preparing said intermediate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-03-12 US disclosed
EP-0663394-A1 Process for preparing 5-aminodihydropyrrole, intermediate thereof and process for preparing said intermediate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-07-19 EP disclosed
US-4432991-A ANALGESICS, FUNGICIDE, BACTERICIDE, ANTIINFLAMMATORY, OR ANTIARTHRITIC AGENTS, ANTIALLERGENS, AND BRONCHODILATOR AMERICAN CYANAMID COMPANY (US) 1984-02-21 US disclosed
EP-0070376-A1 Heterocyclic substituted-amino-pyrazolines AMERICAN CYANAMID COMPANY (US) 1983-01-26 EP disclosed
US-4360680-A ANALGESIC, ANTIINFLAMMATORY AGENT, FUNGICIDE AND BACTERICIDE AMERICAN CYANAMID COMPANY (US) 1982-11-23 US disclosed
US-4320071-A CATALYTIC DISPROPORTIONATION PHILLIPS PETROLEUM COMPANY (US) 1982-03-16 US disclosed